Bebetter Med, Inc. Class ASSE: 688759

Special Report on Deposit, Management, and Actual Use of Raised Funds in 2025

Apr 28, 2026 · Issued by Bebetter Med, Inc. Class A via Shanghai Stock Exchange

Special Report on Deposit, Management, and Actual Use of Raised Funds in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Bebetter Med, Inc. Class A

Announcement on Circulation of Partial Restricted Shares in Offline Placement of Initial Public OfferingApr 21
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Apr 9
Announcement on Changing Some Investment Projects Financed by Raised Funds and the Establishment of a New Special Account for Raised FundsMar 24
Announcement on Voluntary Disclosure of Obtaining Clinical Trial Approval Notification for Iprinosine Hydrochloride for Injection (BEBT-908) Combined with CHOP in the Treatment of Newly Diagnosed Peripheral T-Cell LymphomaMar 14

All Bebetter Med, Inc. Class A news releases